Creatinine levels remained relatively stable in the GLP-1 while increasing from 2.2 mg/dL at baseline to 2.74 mg/dL at 6 months for adults not using a GLP-1
Academic Press, Elsevier, pp 123244
Jun 23, 2025 Learn more about the inspiring story of Cigna Healthcare customer Bobby Neeb
Retatrutides glucagon component is the differentiator, though it also means the compound behaves differently and warrants its own research protocols rather than assuming parity with GLP-1-only peptides
This article breaks down published rates, real annual totals, and total cost of ownership across typical patient profiles, so you can see what each program actually costs across a year of treatment
The mechanism behind blood pressure reduction is multifactorial